Synchronous bilateral breast cancer: one case report

doi:10.3877/cma.j.issn.1674-0807.2025.06.010

Chinese Journal of Breast Disease(Electronic Edition) ›› 2025, Vol. 19 ›› Issue (06): 377-380. doi: 10.3877/cma.j.issn.1674-0807.2025.06.010

Special Issue: ；

• Case Report • Previous Articles Next Articles

Synchronous bilateral breast cancer: one case report

Jing Yang, Jie Gao, Shuqin Li

Received:2024-05-21 Online:2025-12-01 Published:2025-12-24

Abstract

Jing Yang, Jie Gao, Shuqin Li. Synchronous bilateral breast cancer: one case report[J]. Chinese Journal of Breast Disease(Electronic Edition), 2025, 19(06): 377-380.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhrxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0807.2025.06.010

https://zhrxbzz.cma-cmc.com.cn/EN/Y2025/V19/I06/377

Figures/Tables 4

References 16

［1］	Bray F，Laversanne M，Sung H，et al. Global cancer statistics 2022： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2024，74（3）：229-263.
［2］	Gadea J，Ortiz I，Roncero R，et al. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule： clinical and dosimetric outcomes［J］. Clin Transl Oncol，2021，23（9）：1915-1922.
［3］	吕明丽，张晟，刘红，等. 双侧原发性乳腺癌ER、PR及HER-2表达特征及其与预后的关系［J/OL］. 中华乳腺病杂志（电子版），2009，3（1）： 32-40.
［4］	Jobsen JJ，van der Palen J，Ong F，et al. Bilateral breast cancer，synchronous and metachronous； differences and outcome［J］. Breast Cancer Res Treat，2015，153（2）：277-283.
［5］	Simsek M，Aykas F，Yildirim AO. Metachronous bilateral breast cancer diagnosed with primary breast lymphoma and mucinous carcinoma： The first case in the literature［J］. J Cancer Res Ther，2022，18（3）：846-848.
［6］	Li B，Xu W，Cao J，et al. A study of clinical and molecular characteristics in bilateral primary breast cancer［J］. Cancer Med，2023，12（15）：15881-15892.
［7］	Verkooijen HM，Chatelain V，Fioretta G，et al. Survival after bilateral breast cancer： results from a population-based study［J］. Breast Cancer Res Treat，2007，105（3）：347-357.
［8］	Chaudary MA，Millis RR，Hoskins EO，et al. Bilateral primary breast cancer： a prospective study of disease incidence［J］. Br J Surg，1984，71（9）：711-714.
［9］	Chen JJ，Wang Y，Xue JY，et al. A clinicopathological study of early-stage synchronous bilateral breast cancer： a retrospective evaluation and prospective validation of potential risk factors［J］. PLoS One，2014，9（4）：e95185.
［10］	Jiang H，Zhang R，Liu X，et al. Bilateral breast cancer in China： a 10-year single-center retrospective study （2006-2016）［J］. Cancer Med，2021，10（17）： 6089-6098.
［11］	Muhsen S，Moo TA，Patil S，et al. Most breast cancer patients with T1-2 tumors and one to three positive lymph nodes do not need postmastectomy radiotherapy［J］. Ann Surg Oncol，2018，25（7）： 1912-1920.
［12］	Park SH，Lee J，Lee JE，et al. Local and regional recurrence following mastectomy in breast cancer patients with 1-3 positive nodes： implications for postmastectomy radiotherapy volume［J］. Radiat Oncol J，2018，36（4）：285-294.
［13］	Huang TT，Chen AC，Lu TP，et al. Clinical-genomic models of node-positive breast cancer： training，testing，and validation［J］. Int J Radiat Oncol Biol Phys，2019，105（3）： 637-648.
［14］	Zhang L，Zhou M，Liu Y，et al. Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy？An analysis based on RecurIndex assay［J］. Int J Cancer，2021，149（10）：1801-1808.
［15］	Huang JH，Wu XX，Lin X，et al. Evaluation of fixed-jaw IMRT and tangential partial-VMAT radiotherapy plans for synchronous bilateral breast cancer irradiation based on a dosimetric study［J］. J Appl Clin Med Phys，2019，20（9）：31-41.
［16］	Balasubramanian S，Shobana MK. A dosimetric and radiobiological comparison of intensity modulated radiotherapy，volumetric modulated arc therapy and helical tomotherapy planning techniques in synchronous bilateral breast cancer［J］. Asian Pac J Cancer Prev，2022，23（12）： 4233-4241.

Please choose a citation manager

Content to export

Synchronous bilateral breast cancer: one case report

RichHTML

PDF (PC)

Knowledge